Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

NCT01627561 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01627561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01627561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 15, 2012
Completion date
October 6, 2016
Enrollment
148 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus